Combined Treatment of an Intratumoral Injection of Dendritic Cells and Systemic Chemotherapy (Paclitaxel) for Murine Fibrosarcoma
1
조회
0
다운로드
3
인용
0
참고문헌
초록
Abstract
A novel combined treatment of conventional chemotherapy with an intratumoral injection of syngeneic dendritic cells (DCs) has emerged as a potent cancer treatment strategy. In this study, we evaluated the synergistic effect of an intraperitoneal (i.p.) injection of a chemotherapeutic drug, paclitaxel, and an intratumoral (i.t.) injection of syngeneic bone marrow- derived DCs for the treatment of pre-existing fibrosarcoma. Subcutaneous tumors were established using MCA102 fibrosarcoma cells in syngeneic C57BL/6 mice. The results demonstrated that the combined treatment of paclitaxel chemotherapy and the injection of DCs led to complete tumor regression, in contrast to only partial eradication of the tumors with chemotherapy or DCs alone. Furthermore, the tumor-free mice were able to resist a repeat challenge with the same type of tumor. These findings suggest that a combination therapy of systemic chemotherapy along with the intratumoral administration of DCs is a potent treatment strategy for fibrosarcoma.
참고문헌 (17)
- "Dendritic cells and the control of immunity", 392, pp.245~52 (1998)
- "The dendritic cell system and its role in immunogenicity", pp.271~96
- "Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity.", 183, pp.283~7 (1996)
- "Kurts C Cross-presentation a general mechanism for CTL immunity and tolerance", 19, pp.368~73 (1998)
- "Dendritic cells as initiators of tumor immune responses a possible strategy for tumor immunotherapy", 16, pp.117~21 (1995)
- "Dendritic cells in antitumor immune responses Dendritic cells grown from bone marrow precursors but not mature DC from tumor-bearing mice are effective antigen carriers in the therapy of established tumors", 170, pp.111~9
- "Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells", 4, pp.328~32 (1998)
- "Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo", 184, pp.465~72 (1996)
- "DNA-based immunization by in vivo transfection of dendritic cells", 2, pp.1122~8 (1996)
- "Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells", 97, pp.2715~8 (2000)
- "Strategies to improve dendritic cell-based immunotherapy against cancer", 45, pp.48~52 (2004)
- "Combined intratumoral injection of bone marrow-derived dendritic cells and systemic chemotherapy to treat pre-existing murine tumors", 61, pp.7530~5 (2001)
- "Dendritic cells coinjected with tumor cells treated with an anticancer drug to induce tumor rejection", 33, pp.269~76 (2003)
- "Antitumor effect of intratumoral administration of dendritic cell combination with vincristine chemotherapy in a murine fibrosarcoma model", 18, pp.435~47 (2003)
- "Effective combination of chemotherapy and dendritic cell administration for the treatment of advanced-stage experimental breast cancer", 9, pp.285~94 (2003)
- "Promotion of microtubule assembly in vitro by taxol", pp.665~7
- "Altered maturation of dendritic cells by taxol", pp.229~34 (2003)